Orthovita signs Japanese agreement
This article was originally published in Clinica
Executive Summary
US biomaterials company Orthovita has concluded a development and distribution agreement with Japan Medical Dynamic Marketing (JMDM)for Orthovita's VITOSS synthetic cancellous bone void filler. As part of the deal the Japanese company has paid $1 million to acquire approximately 190,000 Orthovita shares.